TMCPX
Price
$55.92
Change
+$0.48 (+0.87%)
Updated
Sep 26 closing price
Net Assets
5.25B
VIMSX
Price
$79.84
Change
+$0.88 (+1.11%)
Updated
Sep 26 closing price
Net Assets
199.16B
Interact to see
Advertisement

TMCPX vs VIMSX

Header iconTMCPX vs VIMSX Comparison
Open Charts TMCPX vs VIMSXBanner chart's image
Touchstone Mid Cap Y
Price$55.92
Change+$0.48 (+0.87%)
VolumeN/A
Net Assets5.25B
Vanguard Mid Cap Index Investor
Price$79.84
Change+$0.88 (+1.11%)
VolumeN/A
Net Assets199.16B
TMCPX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
TMCPX vs. VIMSX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TMCPX is a Hold and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 199B vs. TMCPX (5.25B). VIMSX pays higher dividends than TMCPX: VIMSX (1.35) vs TMCPX (0.27). TMCPX was incepted earlier than VIMSX: TMCPX (23 years) vs VIMSX (27 years). TMCPX (0.90) is less costly to investors than VIMSX (0.17). TMCPX is a more actively managed with annual turnover of: 18.00 vs. VIMSX (16.00). TMCPX has a lower initial minimum investment than VIMSX: TMCPX (2500) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 11.57 vs. TMCPX (-2.48). VIMSX return over 5 years is better than : 70.75 vs. TMCPX (46.59).
TMCPXVIMSXTMCPX / VIMSX
Total Expense Ratio0.900.17529%
Annual Report Gross Expense Ratio0.900.17529%
Fund Existence23 years27 years-
Gain YTD1.26810.84512%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets5.25B199B3%
Annual Yield % from dividends0.271.3520%
Returns for 1 year-2.4811.57-21%
Returns for 3 years41.0655.7474%
Returns for 5 years46.5970.7566%
Returns for 10 years149.75160.6693%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXRX1.400.06
+4.48%
Lexicon Pharmaceuticals
APGE38.220.70
+1.87%
Apogee Therapeutics
ASTS49.09-0.30
-0.61%
AST SpaceMobile
JDZG1.81-0.02
-1.09%
Jiade Limited
LIDR2.36-0.03
-1.26%
AEye